Aug 1, 2011 · Long-term outcome with respect to progression-free survival, overall survival, and relapse rate is superior after auto-allo compared with auto only.
Tandem Autologous/Reduced-Intensity Conditioning Allogeneic ...
ascopubs.org › doi › JCO.2010.32.7312
Progression-free survival at 60 months was significantly better with auto-allo than with allo alone (35% v 18%; P = .001), as was the risk of death and of ...
Jun 20, 2013 · Tandem autologous/reduced-intensity allogeneic transplantation is superior to autologous transplantation alone in multiple myeloma. Abstract.
Jun 20, 2013 · At 96 months progression-free survival (PFS) and overall survival (OS) were 22% and 49% vs 12% (P = .027) and 36% (P = .030) with auto/RICallo ...
Long-term follow-up of auto-auto versus auto-allo in newly diagnosed multiple myeloma patients confirms significant and durable reduction in risk of relapse ...
People also ask
What is the difference between autologous stem cell transplant and allogeneic stem cell transplant?
What is the life expectancy after stem cell transplant for myeloma?
What is a tandem transplant for myeloma?
What is the success rate of allogeneic stem cell transplant for myeloma patients?
Feb 1, 2019 · Our study showed that tandem autologous/minimal intensity allogeneic HCT for MM was safe and characterized by low acute and long-term toxicities.
Long-term follow-up of auto-auto versus auto-allo in newly diagnosed multiple myeloma patients confirms significant and durable reduction in risk of relapse.
In comparison to tandem-auto-SCT, patients assigned to auto-allo-SCT exhibited a higher risk of transplant-related mortality (TRM) (11.9% vs. 4.1%) and non- ...
Aug 1, 2011 · Allogeneic Stem-Cell Transplantation Versus Autologous. Transplantation in Myeloma: Long-Term Follow-Up. Bo Björkstrand, Simona Iacobelli, Ute ...
Jun 20, 2013 · Long-term outcome in patients with multiple myeloma was better with auto/RICallo as compared with auto only and the auto/RICallo approach seemed to overcome ...